In a recent discussion, the outlook for the U.S. stock market heading into 2026 was presented by Mike Wilson, Morgan Stanley’s Chief U.S. Equity Strategist, and Daniel Skelly, Senior Investment Strategist for Morgan Stanley Wealth Management. Both strategists expressed a bullish view for stock performance over the next few years, although they acknowledged the likelihood of increased volatility.
Wilson discussed that inflation still poses a significant risk for both retail and institutional investors, affecting market performance. He noted that while they maintain a bullish perspective moving forward, it is essential to manage risks inherent in the market’s potential volatility. Skelly emphasized the strategies that retail investors can adopt, particularly focusing on sectors that have inherent inflation-hedging qualities.
One area highlighted was investments in the AI infrastructure segment, along with utilities and energy infrastructure, which Skelly identified as not only protective against inflation but also as diversified opportunities. They considered the dominance of the tech giants, often referred to as the “Mag 7,” as a risk for concentration in the equity market, and stressed the importance of diversifying portfolios.
Both strategists pointed out that if inflation were to rise again as the economy improves, this could expand investment opportunities beyond the concentrated winners of the current market. Skelly shared insights into how deregulation and potential mergers and acquisitions might benefit sectors like Financials and Industrials, suggesting a possible resurgence for mid- and small-cap stocks as well.
Turning to specific sectors, the discussion moved to Financials. Skelly mentioned that despite various bullish factors such as a cyclical recovery and favorable market conditions, retail investors have remained hesitant to commit fully to this sector. They agreed that there might be catch-up trades available, particularly within regional banks.
Wilson then steered the conversation towards Healthcare, acknowledging its previous underperformance. Skelly explained that improvements in policy risk as well as positive earnings revisions within sectors such as pharmaceuticals could signal growing optimism. Additionally, he emphasized how AI technologies are anticipated to bring significant improvements and efficiencies in Healthcare, attracting investor interest.
On the topic of consumer trends, Skelly pointed out that the retail landscape is increasingly dominated by a few large platforms, similar to the trend observed in the tech sector. He indicated that there are still opportunities in platforms that focus on market share gains and recurring revenues, even as established global brands face challenges.
Lastly, they addressed the topic of broader infrastructure spending trends, particularly in light of supportive fiscal incentives under recent legislation. Skelly elaborated on the implications for industrial stocks and potential revitalization in sectors that have been stagnant.
As they wrapped up their conversation, Wilson addressed common investor anxieties regarding valuation in a seemingly overbought market. Skelly argued that the market’s current composition, characterized by greater revenue stability driven by advancements such as AI, justifies a higher valuation than historical norms might suggest.
The engaging dialogue highlighted both a cautiously optimistic outlook for U.S. equities and the strategic considerations necessary for navigating the complexities of the current investment landscape.
